From quarterly updates to key announcements, here you can access GSK investor-related information.
GSK Investor Relations. 85. General Enquiries. +44 (0)20 8047 5000. GSK.Investor-Relations@gsk.com. Sarah Elton-Farr. James Dodwell. Global Head of IR. IR ...
Jan 31, 2024 · Forward-looking statements give the Group's current expectations or forecasts of future events. An investor can identify these statements by the ...
Investors Corporate actions · Consumer Healthcare Demerger · Consumer Healthcare Joint Venture · Agreement to acquire TESARO · Debt investors · Feedback ...
Our Investor Relations department, with offices in London and Philadelphia, acts as a focal point for contacts with investors throughout the world. The CEO ...
GSK Investor Relations. General Enquiries. +44 (0)20 8047 5000. GSK.Investor-Relations@gsk.com. Sarah Elton-Farr. Sonya Ghobrial. Global Head of IR. Head of ...
Feb 27, 2022 · Investor relations may be contacted as follows: ... Glaxo Trustees Limited (ii) (in liquidation) ... Glaxo Wellcome Australia Pty Ltd (ii) (iv).
View Research & Development — Discover How GSK Is Getting Ahead Of Disease. Go Behind The Science On Official GSK Site. Discover GSK Advanced Technologies, Research, And Products On Official GSK Site. Pipeline Information. Company Culture. Media & Press Releases. Unite Science. Health Security.
